Tinea barbae
ICD-10 B36.0 is a billable code used to indicate a diagnosis of tinea barbae.
Tinea barbae is a superficial fungal infection affecting the beard area of the face and neck, primarily caused by dermatophytes, particularly Trichophyton species. This condition is characterized by erythematous, scaly patches that may be itchy or painful. It often presents as folliculitis, with pustules or crusting, and can lead to hair loss in the affected areas. Tinea barbae is more common in males due to the presence of facial hair and can be exacerbated by factors such as poor hygiene, humid environments, and close contact with infected individuals or animals. The infection can occur in immunocompromised patients, where the immune response is inadequate to control fungal growth, leading to more severe manifestations. Diagnosis is typically made through clinical examination and confirmed by fungal culture or KOH preparation. Treatment usually involves topical antifungal agents such as clotrimazole or terbinafine, and in more severe cases, systemic antifungal therapy may be necessary. It is crucial to educate patients on proper grooming practices and hygiene to prevent recurrence.
Detailed clinical notes including lesion description, location, and treatment response.
Patients presenting with itchy, scaly patches in the beard area, often with a history of recent grooming or exposure.
Consideration of differential diagnoses and the need for fungal cultures to confirm diagnosis.
Comprehensive history including patient hygiene practices and any immunocompromised conditions.
Patients with facial lesions who may not have seen a dermatologist yet.
Awareness of referral protocols for persistent or severe cases.
When a biopsy is performed to rule out other conditions.
Document the reason for the biopsy and the findings.
Dermatologists may perform biopsies more frequently than primary care providers.
Common treatments include topical antifungal creams such as clotrimazole or terbinafine, and systemic antifungals like itraconazole or fluconazole for more severe cases.